DAVID FOLK: Open Payments
NPI 1265800718 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$800 in 43 payments from 7 companies in 2025. Trend: 2023 $639 · 2024 $854 · 2025 $800
Food & beverage: $800
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $386 |
| Ardelyx, Inc. | 8 | $239 |
| Phathom Pharmaceuticals, Inc. | 4 | $55 |
| Madrigal Pharmaceuticals | 3 | $47 |
| Janssen Biotech, Inc. | 2 | $40 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
| Medtronic, Inc. | 1 | $14 |
Products named: CREON, IBSRELA, RINVOQ, SKYRIZI, VOQUEZNA, REZDIFFRA, TREMFYA, LINZESS.
Industry payments across PA — which companies pay providers there.
